S
3.93
0.61 (18.37%)
| 前收盘价格 | 3.32 |
| 收盘价格 | 3.61 |
| 成交量 | 463,627 |
| 平均成交量 (3个月) | 93,686 |
| 市值 | 763,821,888 |
| 价格/销量 (P/S) | 23.36 |
| 股市价格/股市净资产 (P/B) | 26.16 |
| 52周波幅 | |
| 利润日期 | 13 Feb 2026 |
| 营业毛利率 | -67.73% |
| 营业利益率 (TTM) | -115.65% |
| 稀释每股收益 (EPS TTM) | -0.080 |
| 季度收入增长率 (YOY) | 40.80% |
| 总债务/股东权益 (D/E MRQ) | 25.78% |
| 流动比率 (MRQ) | 3.17 |
| 营业现金流 (OCF TTM) | -12.93 M |
| 杠杆自由现金流 (LFCF TTM) | -14.06 M |
| 资产报酬率 (ROA TTM) | -19.93% |
| 股东权益报酬率 (ROE TTM) | -55.43% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Devices (US) | 混合的 | 看跌 |
| Medical Devices (全球的) | 混合的 | 看跌 | |
| 股票 | SS Innovations International In | - | - |
AIStockmoo 评分
0.9
| 分析师共识 | 0.0 |
| 内部交易活动 | NA |
| 价格波动 | 1.5 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 2.0 |
| 平均 | 0.88 |
|
SS Innovations International Inc is a commercial-stage surgical robotics company focused on transforming patient lives by democratizing access to advanced surgical robotics technologies. The company designs, manufactures, and markets an advanced, next-generation, and affordable surgical robotic system called the SSi Mantra, and the instruments and accessories used with SSi Mantra to perform a wide range of soft-tissue, robotically assisted surgeries. The company earns the majority of its revenue from India. |
|
| 部门 | Healthcare |
| 行业 | Medical Devices |
| 投资方式 | Mid Growth |
| 内部持股比例 | 83.38% |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合